<http://schema.org/headline>
"Novartis announces positive results from final Phase III omalizumab registration study in severe form of chronic skin disease CSU&lt;NOVN.VX&gt;"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.reuters.com/article/2013/10/05/idUSnHUGdk9n+70+ONE20131005>